Today's letter from the Editor
£45000 per annum: Harrington Starr: Quantitative Analyst (Financial Services, ...
Negotiable: Harrington Starr: Application Support Engineer (C++, .NET, VB, Per...
Negotiable: Harrington Starr: C# .NET Software Developer (Client-Side, SQL, VB...
£40000 - £60000 per annum + Benefits + Bonus: Harrington Starr: C# Developer (...
The Business Matrix: Tuesday 27 August 2013
Tradesmen ‘work the longest hours’
Britain’s tradesmen work longer than bankers, as holidays are sacrificed and weekends ignored in a bid to squeeze more jobs in. The average tradesman works between 41 and 50 hours a week, more than bankers, who are at their desk for an average of 40.9 hours; doctors, on 38.4 hours; barristers and judges, 36 hours; and accountants, 35.6 hours, a survey by Screwfix has found.
Telefonica’s bid gets Slim chance
Telefonica, the Spanish mobile giant that owns O2, yesterday raised its bid for Germany’s E-Plus and won the backing of billionaire Carlos Slim, who could have blocked the deal.
Telefonica offered to pay Holland’s KPN €8.55bn (£7.34bn) for E-Plus an increase on the €8.1bn it had offered in July. Mr Slim’s America Movil, the largest single shareholder in KPN with a 30 per cent stake, said it would vote in favour.
China sees signs of stabler growth
China’s government yesterday tried to reassure companies and its public about its economy’s health, saying growth is stabilising after a lengthy decline, and should hit the official target of 7.5 percent for the year. “There are growing signs of stabilisation and also of further growth,” said a spokesman, Sheng Laiyun, at a news briefing. “We are confident we can hit our full-year growth target.”
Cancer drugs boost for Astra
UK drugs giant AstraZeneca took a further step to bolster its pipeline of new cancer drugs yesterday by agreeing to acquire privately held US biotech company Amplimmune for up to $500m (£321m). Amplimmune specialises in developing treatments designed to help the immune system fight cancer. The purchase will give AstraZeneca access to a number of compounds in pre-clinical development.
- 1 Richard Dawkins on babies with Down Syndrome: 'Abort it and try again – it would be immoral to bring it into the world'
- 2 ALS ice bucket challenge co-founder Corey Griffin drowns, aged 27
- 3 World peace? These are the only 11 countries in the world that are actually free from conflict
- 4 Nicki Minaj finally releases predictable 'Anaconda' video
- 5 James Foley 'beheading': Met police warn public watching murder video could be criminal offence